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S U M M A R Y
Objective: To determine the frequency of human papillomavirus (HPV) types and to assess bacterial
vaginosis (BV) possible associations with cervical infections in indigenous Paraguayan women of the
Department of Presidente Hayes.
Methods: This study included 181 sexually active women without cervical lesions. HPV typing was
performed by polymerase chain reaction with primers PGMY 09/11 followed by reverse line
hybridization. BV was diagnosed by the Nugent criteria using the results from a Gram stain smear.
Results: Sixteen percent of women were positive for at least one high risk HPV type (HR-HPV). The most
frequent genotypes were HPV 16 (4.4%), followed by HPV 58 (3.3%), HPV 45 (3.3%), HPV 53 (2.8%) and
HPV 11 (2.8%). A signiﬁcant association between HR-HPV and BV was observed (p=0.01). In addition,
women with BV had a higher frequency of Chlamydia trachomatis (p=0.0007), Trichomonas vaginalis
(p=0.00009), Mycoplasma hominis (p=0.001).
Conclusions: A large variety of HPV genotypes was detected and showed a slightly different pattern from
previous studies on urban women in Paraguay, with the predominance of HR-HPV. Furthermore, the
information of co-infections involved in BV could be useful for the improvement of national prevention
programs, as well as for laboratory surveillance of these genital infections.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Cervical cancer is the fourth most common cancer in women,
with 528,000 new cases and 266,000 deaths in 2012. In Paraguay,
the standardized incidence and mortality rates are 34.2 and
15.7 per 100,000 women, respectively.1
It has been well established that persistent genital infection
with high risk human papillomavirus (HR-HPV) is a necessary
factor for developing cervical cancer.2–4 Over 200 different HPV
genotypes have been identiﬁed, of which about 40 infect the
anogenital mucosa. They are classiﬁed into HR-HPV, low risk (LR-
HPV), and others that are not yet classiﬁed. Fifteen HPV genotypes
are classiﬁed as HR-HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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and twelve as LR-HPV types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81,
and CP6108).5,6 The prevalence of HPV infection and the
distribution of HPV genotypes varies by geographic region and
the severity of the cervical lesion.7–11
Because only HR-HPV persistent infection is not enough for
cervical cancer development, it is considered that other factors
would determine whether an HPV infection will resolve to
normalcy or progress to high-grade lesions (HSILs) or cervical
cancer; among the main risk factors are included: the prolonged
use of hormonal contraceptives, high parity, smoking, co-infection
with other sexually transmitted diseases, bacterial vaginosis (BV)
and immune and nutritional deﬁciencies.4,12 Their inﬂuence in the
HPV infection acquisition and cervical cancer development is
incompletely understood.
BV is characterized by a loss of Lactobacillus species and a
concurrent overgrowth of anaerobic bacteria and the presence of
potentially pathogenic bacteria, such as Bacteroides, Peptococcus,
Ureaplasma urealyticum, and Mycoplasma spp., which are most
frequently detected in the vaginal tract.12 However, the magnitude
of association between co-infections involved in BV and HPV
infection is varied in epidemiological studies and still remains
controversial.12,13
Although some studies have investigated cervical infections in
indigenous women in the Americas,14,15 HPV and BV infections
data in the native communities of Paraguay are limited.14,15
Therefore, the aim of this study was to deepen knowledge of the
epidemiology of cervical infections by determining the frequency
of HPV genotypes, and assessing their BV possible associations
with HPV infections in indigenous Paraguayan women of the
Department of Presidente Hayes, Paraguay, which contains 23% of
the native population of Paraguay.16
2. Materials and methods
2.1. Study design and sample collection
A cross-sectional study of 181 indigenous women from
Presidente Hayes Department was performed. Recruitment is
described in the work of Mendoza et al.17 Brieﬂy, the communities
included were selected in conjunction with the local health
authorities (Health Region XV), taking into account the availability
of health workers who could facilitate access to women and
perform sample collection. Indigenous communities were visited
to explain the project and invite women to participate. The
localities were found at a distance between 30 and 434 km from
Asuncion, the capital of Paraguay. After selecting communities, the
selection of women was conducted by sampling consecutive
women who had sexual intercourse, were not pregnant, did not
have mental illnesses, and did not have drug (vaginal ovules) or
surgical (LEEP, cone hysterectomy, or other) treatments during the
study period (October 2010 to November 2011). Of the 181 women
included in the study, ethnicity was as follows: 40 were Maka´,
23 were Nivacle´, 33 were Sanapana´, 51 were South Enxet, and
34 were Toba-Qom. This population constitutes 30% of the women
population greater than or equal to 13 years.
Prior to sampling, all women signed a consent form and also
completed a questionnaire about sociodemographics and gynae-
cological history. Subsequently, a gynaecologist took two cervical
samples: one for cytological diagnosis and the other for the
detection and typing of HPV. Data collection and analysis of results
respected the conﬁdentiality and anonymity of the patient. Each
patient received the results of HPV detection and cytology. The
local medical team conducted the monitoring and treatment of
women.2.2. Cytological diagnosis
Cervical brushing was performed by a trained gynaecologist.
Results were reported according to the Bethesda 2001 System as
negative for squamous intraepithelial lesions (NSIL), low grade
squamous intraepithelial lesions (LSIL, which includes cervical
intraepithelial neoplasm (CIN) I and/or HPV), high grade squamous
intraepithelial lesions (HSIL, which includes CIN II and CIN III), or
squamous cell carcinoma (SCC).18
2.3. Detection and typing of HPV
DNA extraction of cervical specimens was performed according
to the methodology described by Mendoza et al.11 in which the cell
pellet was digested with proteinase K.
Detection and typing of HPV was performed according Estrade
et al.19 Brieﬂy, generic PCR was performed using biotinylated
PGMY09/11 primers, and the ampliﬁcation product obtained was
analysed by reverse line hybridization (RLB). Type-speciﬁc probes
corresponding to 32 HPV types were used (types 16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59, 66, 68, 6, 11, 26, 34, 40, 42, 43, 44, 53, 54,
55, 57, 69, 70, 73, 82, 83 [MM7], and 84 [MM8]). This approach
allows the evaluation of the quality of the DNA sample by co-
ampliﬁcation of a 230 bp HLA fragment. To detect positive samples
for other HPV types not included in the RLB probes, the
ampliﬁcation products obtained using PGMY09/11 primers of all
RLB negative samples were subjected to electrophoresis on
polyacrylamide gels to determine whether an HPV-speciﬁc band
of 450 bp was present. In particular, in the case of HPV studies, the
criteria adopted for considered a positive woman for HPV was a
positive result in PGMY09/11. The criteria for the follow-up was
women who tested positive for HPV but had negative cytology
result would be followed with a control in a year; women who
tested positive for both HPV and cytology, would be referred to
colposcopy.
For the classiﬁcation of HPV genotypes into HR-HPV, probable
HR-HPV, and LR-HPV, the Mun˜oz et al. classiﬁcation was used.6
BV was diagnosed by the Nugent criteria using the results from
a Gram stain smear of the vaginal swab.20 A score of 0 to 3 was
considered normal, 4 to 6 was classiﬁed as abnormal vaginal ﬂora
(or intermediate), and 7 to 10 was deﬁned as BV.
Detections of others infections was performed by either Gram
staining and/or cultura (for Candida sp., Trichomonas vaginalis,
Gardnerella vaginalis), serological methods (for syphilis) and
molecular methods (for Chlamydia trachomatis, Mycoplasma
hominis y Ureaplasma urealyticum) as is detailed in Mendoza et al.17
2.4. Statistical Analysis
Data analysis was performed using Epi Info version 3.5.3
(Centers for Disease Control and Prevention, Atlanta, GO, USA). To
determine the frequency of HPV types in the population, single and
multiple HPV infections were considered either separately or
combined. HPV frequency was estimated within broad age groups
(<30, 30–39, 40–49 and >50 years).
To estimate the possible association between the variables
analysed, the Chi-square test was used, and p  0.05 was
considered statistically signiﬁcant.
3. Results
A total of 42/181 women (23%; 95%CI: 17%–30%) were positive
for HPV, including 24 women (13%; 95%CI: 8%–19%) with single
infections, 17 with multiple infections (9%; 95%CI: 5%–14%), and
one woman with HPV infection of an undetermined type (0.6%;
95%CI: 0%–3%). Women with HPV infections had an earlier age of
Table 1
HPV frequency according socio-demographic and sexual characteristics of 181 indigenous women
Characteristics Total
(n: 181)
HPV positive women (n=42) HPV negative women (n=139) P
Age (years)
Median (Interquartile range) 30 (23-41) 27 (20-40) 30 (24-42)
<27 (n %) 64 19 (30) 45 (70) p=0.13
27 (n %) 117 23 (20) 94 (80)
Education (n %)
Illiterate / Elementary school 168 40 (24) 128 (76) p=0.49
High school 13 2 (15) 11 (85)
Age at 1st sexual intercourse(years)
Median (Interquartile range) 16 (13-19) 16 (14-18) 17(14-20)
16 (n %) 105 31 (30) 74 (70) p=0.018
16 (n %) 76 11 (14) 65 (86)
n sexual partners
Median (Interquartile range) 1 (1-2) 2 (1-3) 1 (1-2)
2 (n %) 28 11 (39) 17 (61) p=0.028
2 (n %) 153 31 (20) 122 (80)
Pregnancies
Yes (n %) 166 39 (23) 127 (77) p=0.52
No (n %) 15 3 (20) 12 (80)
n pregnancies (n=166)
Median (Interquartile range) 3 (1-5) 3 (2-5) 3 (1-5)
>3 (n %) 80 18 (22) 62 (78) p=0.77
3 (n %) 86 21 (24) 65 (76)
Oral contraceptive use
Yes (n %) 107 23 (21) 84 (79) p=0.51
No (n %) 74 19 (26) 55 (74)
Smoking
Yes (n %) 39 11 (28) 28 (72) p=0.40
No (n %) 142 31 (22) 111 (78)
Previous Cytology
No (n%) 130 28 (22) 102 (78) p=0.40
Yes (n%) 51 14 (27) 37 (73)
HPV, human papillomavirus; IC, Conﬁdence Interval.
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number or sexual partners (two or more, p = 0.028), Table 1.
Sixteen percent of women (29/181) were positive for at least one
HR-HPV type, 5% (9/181) for at least one type of probable HR-HPV,Table 2
Frequency of HPV genotypes among indigenous women of the Department of Presiden
Total (n=181)a Women with single infectio
HPV 42 24 
HR-HPV 29 (16) 13 
16 8 (4.4) 4 
18 1 (0.6) 0 
31 4 (2.2) 0 
35 1 (0.6) 1 
39 2 (1.1) 0 
45 6 (3.3) 2 
51 1 (0.6) 0 
52 3 (1.7) 1 
56 1 (0.6) 0 
58 6 (3.3) 3 
59 1 (0.6) 1 
68 2 (1.1) 0 
73 3 (1.7) 1 
82 3 (1.7) 0 
Probable HR-HPV 7 (3.9) 5 
53 5 (2.8) 3 
66 3 (1.6) 2 
LR-HPV 19 (10.5) 5 
6 2 (1.1) 0 
11 5 (2.8) 2 
44 3 (1.7) 1 
54 2 (1.1) 0 
70 1 (0.6) 0 
83 4 (2.2) 0 
84 4 (2.2) 2 
HPV, human papillomavirus; HR-HPV, high risk oncogenic HPV; LR-HPV, low risk onco
a Frequency of HPV genotypes detected in women with single and multiple infectio
b Frequency of HPV genotypes detected in women with multiple indigenous infectioand 11% (19/181) for at least one type of LR-HPV. The most common
type was HPV 16 (4.4%), followed by HPV 58 (3.3%), HPV 45 (3.3%),
HPV 53 (2.8%), and HPV 11 (2.8%), Table 2. All women had a NSIL
cytology result, and 14% (95%CI: 9%–20%) had inﬂammatory cytology.te Hayes
n Women with multiple infectionb Undetermined type
17 1
16
4
1
4
0
2
4
1
2
1
3
0
2
2
3
2
2
1
14
2
3
2
2
1
4
2
genic HPV.
ns.
n.
Table 3
Frequency of Nugent score according to HPV and HR-HPV results oﬁndigenous women
Nugent score HPV Positive
n (%)
HPV Negative
n (%)
P HR-HPV Positive
n (%)
HR-HPV Negative
n (%)
P
0–3 (normal), n: 92 13 (31) 79 (57) 0.0033 8 (27.5) 84 (55.3) 0.006
4–6 (intermediate), n:32 11 (26) 21 (15) 0.10 6 (20.7) 26 (17.1) 0.64
7–10 (BV), n: 57 18 (43) 39 (28) 0.07 15 (51.7) 42 (27.6) 0.01
Total 42 (100) 139 (100) 29 (100) 152 (100)
HPV, human papillomavirus; HR-HPV, high risk oncogenic HPV; BV, bacterial vaginosis.
Table 4
Frequency of genital infections according to bacterial vaginosis results of
indigenous women
Variables BV (n=57)
n (%)
No BV (n=124)
n (%)
P
Gardnerella vaginalis 55 (96.5) 28 (22.6) 0.00001
Chlamydia trachomatis 12 (21.0) 6 (4.8) 0.0007
Trichomonas vaginalis 13 (22.8) 5 (4.0) 0.00009
Syphilis (VDRL & IgG*) 10 (17.5) 11 (8.9) 0.09
Candida sp 2 (3.5) 11 (8.9) 0.32
Mycoplasma hominis 27 (47.4) 29 (23.4) 0.001
Ureaplasma urealyticum 11 (19.3) 26 (21.0) 0.796
BV, bacterial vaginosis.
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were positive for BV, 32 (17.7%; 95% CI 12.4% to 24.0%) had an
abnormal vaginal ﬂora (or intermediate) and 92 (50.8%; 95% CI
43.3% to 58.3%) had a normal vaginal ﬂora. Women with vaginal
normal ﬂora had lower frequency of HPV infection. In addition, a
signiﬁcant association between HR-HPV and BV was observed
(Table 3).
No signiﬁcant associations between sociodemographic, sexual
characteristics and the present of BV were seen (data not shown).
However, women with BV had a signiﬁcant higher frequency of
Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma
hominis infections (Table 4).
4. Discussion
Few studies can be found in the literature regarding epidemio-
logical surveys of sexual transmitted infections on American
Indian populations, being South American tribes particularly
ignored. This report provides the ﬁrst data on the frequency of
HPV genotypes, BV and the evaluation of their associations with
possible risk factors among indigenous women in Paraguay.
The any-type HPV prevalence in these women (23.2%) was
comparable to those found by Mendoza et al. (20.8%) in
Paraguayan Caucasian women with negative cytology, but lower
than the frequency detected in previous studies performed with
Guarani and Quechua Argentine indigenous (64% and 52%,
respectively), Brazilian Amazon (42.85%) and Venezuelan Amazon
(57%) tribes; however, the HPV prevalence detected in this study
was higher than the 13.2% observed in a meta-analysis including
South American urban women with normal cytology, according it
was previously discussed in Mendoza et al.17
In the present study, HPV 16 was the most common genotype
found in single and multiple infections, which is similar to previous
reports.7–11,21 Cohort studies have found that women with
persistent HPV 16 infection are at a higher risk of developing
HSIL than women infected with other HR-HPV types.22–24 The HPV
16 prevalence that we found was 4.4% (95%CI: 1.9%–8.5%), which is
higher than the global prevalence in women with normal cytology
(3.2%), but is similar to local reports (4.3% and 5.5%).7,11,21
However, the HPV 16 prevalence that we report is much lower
than those obtained in indigenous populations from Argentina(52% and 64% in Quechua and Guarani women, respectively).14,15
These studies also found more risk factors for acquiring HPV
infection than in the present study, such as early sexual exposure,
multiple sexual partners, and a higher number of pregnancies per
woman. The discrepancies may be due to differences in the applied
genotyping strategies, but also to own socio-cultural and
environmental conditions of each community with semi-closed
characteristics.
After HPV 16, HPV 45 and 58 were the most commonly detected
genotypes. This type-speciﬁc prevalence was slightly different
from the result reported in previously studies conducted in
Asuncio´n in NSIL Paraguayan women. Mendoza et al. observed a
frequency of HPV 31/58 of 2.4% each, Rolon et al. observed a
frequency of HPV 31/35/58 of 2.2% each, and both studies observed
a lower frequency of HPV 45 than we report (1.4% by Mendoza et al.
and 1.1% by Rolon et al.)11,21
It is important to underline the higher HPV 45 prevalence
reported in this study, because it is not typically between the most
common genotype observed in women with normal cytology.25
However, the detection of HPV 45 is very important because of its
presence in cervical adenocarcinomas; in the study of Sanjose
et al.9 it was detected together with HPV 16 and 18 in almost 94% of
cases of invasive cervical cancer. In addition, Sanjose et al.9 and
Mun˜oz et al.26 observed a faster development of cervical cancer in
women positive for HPV 16, 18, and 45 compared with women
with cervical cancer with other HR-HPV genotypes. Therefore, one
might suggest more careful monitoring in young women with
persistent infection with HPV 45 (as has been proposed for HPV
16 and 18) to prevent the development of lesions and cancer.
Beyond differences in type-speciﬁc frequencies observed in
different reports, these data reconﬁrm the high prevalence of
HR-HPV, even in non-pathological cytology.
In this study, a higher frequency of multiple infections was
detected (9.4%) than reported by Mendoza et al.11 in non-
indigenous women with NSIL (4.3%). There is controversy
regarding whether multiple infections with HPV are related to a
higher risk of development of cervical lesions.27,28 However, laser-
capture microscopy (LCM)-polymerase chain reaction (PCR)
conﬁrms that only 9% of histologic CIN2/3 is associated
with multiple HR-HPV types and each lesion was associated with
a single HR-HPV infection.29
A signiﬁcant association was observed between HPV infection
and ﬁrst sexual intercourse at 16 years of age or younger
(p = 0.018), as well as a greater number of sexual partners (more
than two) (p = 0.028). These results are in agreement with several
studies.30–32 Regarding the number of sexual couples, some studies
report a higher probability of acquiring HPV infection in women
with many sexual partners and this fact is one of the most
important risk factors for acquiring an HPV infection.33,34
Determining the viral type distribution in native communities
is of special epidemiological interest, because it constitutes a
potential infective reservoir available for viral spreading into new
populations once contacts begin to be established. Another point to
take into account is that these groups often migrate among
settlements located in northeastern Argentina and southern
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of the Guarani tribes and its agricultural practices. During this
transit, contacts with white population are beginning to be
established, confronting people to different sanitary conditions
and hygiene standards, making transmission of infectious diseases
more likely.
In this study was observed a high frequency of BV (31.5%).
Studies have now conclusively shown that lactobacilli-dominated
are associated with a healthy vaginal micro-environment and that
BV is best described as a polybacterial dysbiosis: the Lactobacillus
sp load decreases, and both the diversity and bacterial load of other
(facultative) anaerobic bacteria increase.35,36 Furthermore, in
agreement with others studies, we observed an association
between BV and HR-HPV, Trichomonas vaginalis, Chlamydia
trachomatis.37–39 These results suggest that in presence of BV it
is necessary to implement a joint screening of other genital
infections of clinical importance.
For the majority of women (72%), this was the ﬁrst time they
had been screened by cervical cytology. This adds value to the
present study by allowing women with poor access to the health
system the chance to receive a gynaecological test and health care
information, which is crucial in the cervical cancer prevention.
5. Conclusion
This work conﬁrms the high prevalence of HPV infection in
cross-sectional measurements among aboriginal women from
Paraguay with normal cytological ﬁndings, and it further indicates
that the vast majority of detected HPV infections include high-risk
types. This result could explain in part the high cervical cancer
incidence in this country. The study had the additional social value
of permitting gynaecological screening access and health care
education to many indigenous women of Paraguay. In addition,
there was observed an association between BV and HR-HPV,
Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma
hominis. This information could be used by national health
authorities for the improvement of prevention programs, as well
as for laboratory surveillance of these genital infections.
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